文献速递肥胖与代谢综合征糖尿病

PREDIMED-Plus 限能量地中海饮食运动干预一年减重与心血管风险结果

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
PubMed 文献 · Diabetes Care · 2018-11-02

PREDIMED-Plus 将 626 名 55–75 岁超重/肥胖代谢综合征成人随机分为强化减重生活方式干预组与对照组,干预组一年平均减重 3.2 kg,对照组 0.7 kg,组间差 -2.5 kg(95%CI -3.1 至 -1.9)。干预组体重下降≥5% 者占 33.7%,对照组 11.9%(P<0.001),腰围、空腹血糖、甘油三酯与 HDL 胆固醇等心血管风险因素均显著改善(P<0.002)。

要点

  • 强化限能量地中海饮食加运动干预一年平均减重 3.2 kg,对照组 0.7 kg。
  • 干预组 33.7% 实现体重下降≥5%,显著高于对照组 11.9%。
  • 合并或高危糖尿病者血糖控制与胰岛素敏感性亦获改善。

核心结论

  • 12 个月强化生活方式干预可有效降低超重/肥胖代谢综合征老年人的体脂并改善心血管风险因素。
  • 该干预对合并或高危糖尿病者的血糖控制与胰岛素敏感性同样有益。

研究设计与样本

  • 随机对照试验,纳入 626 名 55–75 岁超重/肥胖且伴代谢综合征的成人,随机分为强化减重生活方式干预组与对照组。
  • 干预基于限能量地中海饮食、体力活动促进与行为支持;主要结局为体重变化,次要结局为心血管风险标志物变化。

主要发现

  • 12 个月后干预组平均减重 3.2 kg,对照组 0.7 kg(P<0.001),组间平均差 -2.5 kg(95%CI -3.1 至 -1.9)。
  • 体重下降≥5% 者在干预组占 33.7%,对照组占 11.9%(P<0.001)。
  • 与对照组相比,干预组腰围、空腹血糖、甘油三酯与 HDL 胆固醇显著改善(P<0.002)。
  • 干预组胰岛素抵抗、HbA1c 及瘦素、白介素-18、MCP-1 水平的下降幅度大于对照组(P<0.05)。
  • 合并糖尿病前期/糖尿病的干预组受试者血糖控制、胰岛素敏感性、甘油三酯与 HDL 胆固醇均较对照组显著改善。

临床怎么用

  • 对超重/肥胖伴代谢综合征的老年人群,可考虑采用限能量地中海饮食联合运动与行为支持的强化生活方式干预以减重并改善心血管风险。
  • 对合并或高危糖尿病者,该干预有助于改善血糖控制与胰岛素敏感性。

局限性

  • 本文报告的是 12 个月中期结果,长期心血管事件影响尚未确定。
  • 样本量 626 例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The long-term impact of intentional weight loss on cardiovascular events remains unknown. We describe 12-month changes in body weight and cardiovascular risk factors in PREvención con DIeta MEDiterránea (PREDIMED)-Plus, a trial designed to evaluate the long-term effectiveness of an intensive weight loss lifestyle intervention on primary cardiovascular prevention. RESEARCH DESIGN AND METHODS: Overweight/obese adults with metabolic syndrome aged 55-75 years (n = 626) were randomized to an intensive weight loss lifestyle intervention based on an energy-restricted Mediterranean diet, physical activity promotion, and behavioral support (IG) or a control group (CG). The primary and secondary outcomes were changes in weight and cardiovascular risk markers, respectively. RESULTS: Diet and physical activity changes were in the expected direction, with significant improvements in IG versus CG. After 12 months, IG participants lost an average of 3.2 kg vs. 0.7 kg in the CG (P < 0.001), a mean difference of -2.5 kg (95% CI -3.1 to -1.9). Weight loss ≥5% occurred in 33.7% of IG participants compared with 11.9% in the CG (P < 0.001). Compared with the CG, cardiovascular risk factors, including waist circumference, fasting glucose, triglycerides, and HDL cholesterol, significantly improved in IG participants (P < 0.002). Reductions in insulin resistance, HbA1c, and circulating levels of leptin, interleukin-18, and MCP-1 were greater in IG than CG participants (P < 0.05). IG participants with prediabetes/diabetes significantly improved glycemic control and insulin sensitivity, along with triglycerides and HDL cholesterol levels compared with their CG counterparts. CONCLUSIONS: PREDIMED-Plus intensive lifestyle intervention for 12 months was effective in decreasing adiposity and improving cardiovascular risk factors in overweight/obese older adults with metabolic syndrome, as well as in individuals with or at risk for diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, et al. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Diabetes Care. 2018. PMID: 30389673. doi:10.2337/dc18-0836

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。